Skip to content

Frontlight ResearchEarly access

Trial site

Celan SA (Site 0705)

Guatemala City, 01010, GuatemalaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Gastric and oesophageal cancer

Closed trials

Completed
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)
NCT03675737· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Celan SA (Site 0705): trial site – Frontlight Research